GLP-1Most PopularHover to zoomQualified Research Reference
Semaglutide
Semaglutide is documented for controlled research models and literature-based evaluation only.
- Regular
- $119.99
- Elite Member−10%
- $107.99
Semaglutide is a GLP-1 receptor agonist analog supplied as a lyophilized research peptide. Produced under controlled conditions for laboratory investigation.
Commonly studied in glycemic regulation, incretin biology, gastric emptying kinetics, and cardiometabolic research models.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
Semaglutide: investigational profile.
Research Mechanism
A GLP-1 receptor agonist analog investigated for post-prandial glucose kinetics, incretin-mediated satiety signaling, and gastric-emptying rates in metabolic models.
Investigational Profile
Peer-reviewed characterization has accumulated since the mid-2010s across glycemic-regulation, cardiometabolic, and appetite-pathway studies, forming the reference incretin against which newer dual and triple agonists are compared.
Research Study Window
Weekly-dosing kinetics keep most laboratory arms in the four- to twelve-week range so steady-state receptor engagement and satiety endpoints can be documented under consistent conditions.
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C187H291N45O59
- Molar Mass
- 4113.6 g/mol
- Amino Acid Sequence
- H-Aib-EGTFTSDVSSYLEGQAAKEFIAWLVRGRG-OH (K26 conjugated to γGlu-2xOEG-C18 diacid)
- Synonyms
- GLP-1 analog, long-acting incretin mimetic
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
